I’m drawing a line in the sand

Four bloggers “liked” Mike Sedona’s post about how being gay is an abomination and is a death-worthy crime.  Shame on all of you.

https://painkills2.wordpress.com/2015/05/02/i-will-not-tolerate-hate/

Do you follow or “like” posts on this asshole’s blog?  Then I declare you guilty by association. Maybe it’s not fair, but I feel very strongly about those who spread hate and bigotry.  And if you keep giving acceptance to this idiot, then you’re part of the problem.  I don’t care if some of his posts are likeable or not.  I don’t care if your religion demands that you have backward beliefs about gay people.  I don’t care if you’re just paying back Mr. Sedona’s likes on your blog.

Be his blogging friend if you want.  This is a free country.  But I can see each and every one of you, and if you frequent his blog, then please don’t visit mine.  This is my line in the sand.

Inappropriate Opioid, Barbiturate Prescribing Common for Migraine

http://www.pharmacytimes.com/news/inappropriate-opioid-barbiturate-prescribing-common-for-migraine

Opioids and barbiturates are commonly prescribed as first-line migraine treatments, even though clinical guidelines recommend them only as a last resort. A recent study presented at the American Headache Society’s 2015 annual scientific meeting found about 1 in 5 patients presenting to a headache center reported taking opioids or barbiturates at the time, and a quarter of them had been receiving the drugs for more than 2 years…

Rolee Pathak Das, PharmD, BCPS, clinical associate professor at the Rutgers University Ernesto Mario School of Pharmacy, told Pharmacy Times that pharmacists should be more patient-focused when they are dispensing drugs, especially prescription pain medications. “Pharmacists should not just say, ‘Let’s get the medication prescribed to the patient,’ but [rather], ‘Let’s get the right medication, for the right reason, at the right time, and in the best form to improve overall care,’” Dr. Das said.

http://www.consumerreports.org/cro/2013/03/treating-migraine-headaches-with-triptans/index.htm

But you should know that triptans temporarily narrow blood vessels, so they should not be taken by people with certain conditions, including coronary artery disease or angina (chest pain), and peripheral vascular disease. People who have had a heart attack or stroke, have uncontrolled high blood pressure, or have migraines that are accompanied by weakness or paralysis in an arm or leg, vertigo, ringing in the ears, or speech difficulties, should also avoid triptans.

In addition, triptans should be prescribed with caution for those with risk factors for vascular disease, such as men over 40, women over 55, and anyone who smokes, has high cholesterol, diabetes, a family history of early heart disease or stroke, or is significantly overweight.

The seven available triptans (plus one combination pill) differ in their effectiveness and the side effects they cause. They are fairly expensive (three—naratriptan, rizatriptan, and sumatriptan—are now available as generics), ranging from $12 to $46 per pill. The nasal spray and injectable forms cost more…

https://en.wikipedia.org/wiki/Triptan

Triptans are a family of tryptamine-based drugs used as abortive medication in the treatment of migraines and cluster headaches. They were first introduced in the 1990s. While effective at treating individual headaches, they do not provide preventative treatment and are not considered a cure…

Triptans have few side effects if used in correct dosage and frequency. The most common adverse effect is recurrence of migraine. A systematic review found that “rizatriptan 10 mg was the only triptan with a recurrence rate greater than that of placebo”…

There is the potential for life-threatening serotonin syndrome (a syndrome of changes in mental status, autonomic instability, neuromuscular abnormalities, and gastrointestinal symptoms) in patients taking triptans and selective serotonin reuptake inhibitors (SSRIs) or selective serotonin/norepinephrine reuptake inhibitors (SNRIs) at the same time…